Alterations in the pattern of dopaminergic markers in attention-deficit/ hyperactivity disorder;Alteraciones de los patrones de los marcadores de la dopamina en el trastorno por déficit de atención e hiperactividad

Revista de Neurologia

Volumn 42, Issue SUPPL. 2, 2006, Pages

  Díaz Heijtz, Rochellys ^a,c   Mulas, F ^b   Forssberg, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HOSPITAL INFANTIL LA FE   (Spain)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

ADHD; DAT; Dopamine; PET; SPECT; Striatum

Indexed keywords

CATECHOLAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; METHYLPHENIDATE; RUBIFEN; UNCLASSIFIED DRUG;

ATTENTION DEFICIT DISORDER; BRAIN DYSFUNCTION; CONFERENCE PAPER; DOPAMINE BLOOD LEVEL; DOPAMINE METABOLISM; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; MESENCEPHALON; MOLECULAR GENETICS; NEUROBIOLOGY; NEUROTRANSMISSION; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DOPAMINE; HUMANS; RECEPTORS, DOPAMINE;

EID: 34548734156     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Barkley RA. Attention deficit disorder: a handbook for diagnosis and treatment. New York: Guilford Press; 1990.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4 ed. Washington DC: APA; 1994.
3. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57: 1313-23.
4. Artigas-Pallarés, J. Comorbilidad en el trastorno por déficit de atención/hiperactividad. In Mulas F, ed. Trastorno por déficit de atención con hiperactividad. Barcelona: Viguera; 2004. p. 81-108.
5. Solanto MV. Attention-deficit/hyperactivity disorder: clinical features. In Solanto MV, Arnsten AFT, Castellanos FX, eds. Stimulant drugs and ADHD basic and clinical neuroscience. New York: Oxford University Press; 2001. p. 3-30.
6. Castellanos FX, Tannock R. Neuroscience of attention-deficit/ hyperactivity disorder: the search for endophenotypes. Nat Neurosci 2002; 3: 617-28.
7. Le Moal M, Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev 1991; 71: 155-234.
8. Robbins TW. Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol 2005; 493: 140-6.
9. Volkow ND, Wang GJ, Fowler JS, Ding YS. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57: 1410-5.
10. Taylor JR, Jentsch J. Stimulant effects on striatal and cortical dopamine systems involved in reward-related behaviour and impulsivity. In Solanto MV, Arnsten AFT, Castellanos FX, eds. Stimulant drugs and ADHD basic and clinical neuroscience. New York: Oxford University Press; 2001. p. 104-33.
11. Volkow ND, Wang GJ, Fowler JS, Fischman M, Foltin R, Abumrad NN, et al. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sci 1999; 65: 7-12.
12. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 1998; 155: 1325-31.
13. Volkow ND, Wang GJ, Fowler JS, Logan J, Gerasimov M, Maynard L, et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001; 21: 1-5.
14. Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, et al. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry 2004; 161: 1173-80.
15. Gainetdinov RR, Caron MG. Monoamine transporters: from genes to behaviour. Annu Rev Pharmacol Toxicol 2003; 43: 261-84.
16. Madras BK, Miller GM, Fischman AJ. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57: 1397-409.
17. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, et al. The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 1995; 15: 1714-23.
18. De la Gaza R II, Madras BK. (3H)PNU-101958, a D4 dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of nonhuman primate brain. Synapse 2000; 37: 232-44.
19. Falkenburger BH, Barstow KL, Mintz M. Dendrodendritic inhibition through reversal of dopamine transport. Science 2001; 293: 2465-70.
20. Ingram SL, Prasad BM, Amara SG. Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat Neurosci 2002; 5: 971-8.
21. Dougherty DD, Bonad AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. Dopamine density in patients with attention deficit hyperactivity. Lancet 1999; 354: 2132-3.
22. Barkley GB. The ADHD report non-archival newsletter. Vol. 9. New York: Guilford Publications; 2001.
23. Cheon KA, Ryu YH, Kim YK, Namkoong K, Kim CH, Lee JD. Dopamine transporter density in the basal ganglia assessed with (123I)IPT SPET in children with attention deficit hyperactivity disorder. Eur J Nucl Med Mol Imaging 2003; 30: 306-11.
24. Dresel S, Krause J, Krause KH, LaFougere C, Brinkbaumer K, Kung HF, et al. Attention deficit hyperactivity disorder: binding of [99mTc] TRO-DAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med 2000; 27: 1518-24.
25. Spencer TJ, Biederman J, Madras BK, Faraone SV, Dougherty DD, Bonad AA, et al. In vivo neuroreceptor imaging in attention-deficit hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry 2005; 57: 1293-300.
26. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder. Effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 2000; 285: 107-10.
27. Van Dyck CH, Quinlan DM, Cretella LM, Staley JK, Malison RT, Baldwin RM, et al. Unaltered dopamine transport availability in adult attention deficit hyperactivity disorder. Am J Psychiatry 2002; 159: 309-12.
28. Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. Reduced midbrain dopamine transporter binning in male adolescents with attentiondeficit/ hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry 2005; 57: 229-38.
29. Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM. Striatal contribution to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci 2004; 19: 755-60.
30. Schrimsher GW, Bilingsley RL, Jackso EF, Moore BD III. Caudate nucleus volume asymmetry predicts attention-deficit hyperactivity disorder (ADHD) symptomology in children. J Child Neurol 2002; 17: 877-84.
31. Vles JS, Feron FJ, Hendriksen JG, Joles J, Van Kroonenburgh MJ, Weber WE. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD). Neuropediatrics 2003; 34: 77-80.
32. Ernst M, Zmetkin AJ, Matochik JA, Jons PH, Cohen RM. Dopa decarboxylase activity in attention deficit disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J Neurosci 1998; 18: 5901-7.
33. Ernst M, Zmetkin AJ, Matochik JA, Pascualvaca D, Jons PH, Cohen RM. High midbrain 18F-DOPA accumulation in children with ADHD. Am J Psychiatry 1999; 156: 1209-15.
34. Ilgin N, Senol S, Gucuyener K, Gokcora N, Sener S. Is increased D2 receptor availability associated with response to stimulant medication in ADHD? Dev Med Child Neurol 2001; 43: 755-60.
35. Rosa Neto P, Lou H, Cumming P, Pryds O, Gjedde A. Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth: Correlation with attention deficit. Ann N Y Acad Sci 2002; 965: 434-9.
36. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002; 288: 1740-8.
37. Hart EL, Lahey BB, Loeber R, Applegate B, Frick PJ. Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study. J Abnorm Child Psychol 1995; 23: 729-49.